Structure Therapeutics Inc Adr (GPCR)

Apr 01, 2025

Predicting Upstart Holdings Inc’s (UPST) earnings for the current quarter - uspostnews.com

Apr 01, 2025

Mar 28, 2025

GPCR stock touches 52-week low at $19.29 amid market challenges - Investing.com Canada

Mar 28, 2025

Mar 28, 2025

Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - Defense World

Mar 28, 2025

Mar 20, 2025

Oral Proteins and Peptides Market Know the Scope and Trends As Revealed In New Report - WhaTech

Mar 20, 2025

Mar 19, 2025

Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Xoma (XOMA) - The Globe and Mail

Mar 19, 2025

Mar 17, 2025

Acute Bacterial Skin and Skin-Structure Infection Market - openPR

Mar 17, 2025

Mar 16, 2025

Jones Financial Companies Lllp Raises Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Mar 16, 2025

Mar 16, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by Assetmark Inc. - Defense World

Mar 16, 2025

Mar 15, 2025

Analysts Update Their Estimates For Structure Therapeutics Inc ADR - Stocks Register

Mar 15, 2025

Mar 11, 2025

GPCR Stock Hits 52-Week Low at $19.61 Amid Market Challenges - Investing.com Canada

Mar 11, 2025

Mar 10, 2025

Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics - Nature.com

Mar 10, 2025

Mar 10, 2025

Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality - The Globe and Mail

Mar 10, 2025

Mar 07, 2025

Structure Therapeutics (GPCR) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 07, 2025

Mar 06, 2025

Research Analysts Issue Forecasts for GPCR Q4 Earnings - Defense World

Mar 06, 2025

Mar 05, 2025

Q1 Earnings Estimate for GPCR Issued By Leerink Partnrs - Defense World

Mar 05, 2025

Mar 05, 2025

Structure Therapeutics, Inc.: Strong Pipeline and Financial Stability Underpin Buy Rating Despite Price Target Reduction - TipRanks

Mar 05, 2025

Mar 04, 2025

Structure Therapeutics Inc ADR’s (NASDAQ: GPCR) Stock Price Continues To Fall - Stocks Register

Mar 04, 2025

Mar 03, 2025

Leerink cuts Structure Therapeutics target to $60, keeps outperform - Investing.com India

Mar 03, 2025

Mar 03, 2025

Structure Therapeutics (NASDAQ:GPCR) Research Coverage Started at William Blair - Defense World

Mar 03, 2025

Mar 03, 2025

Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World

Mar 03, 2025

Mar 03, 2025

Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $81.29 - Defense World

Mar 03, 2025

Mar 01, 2025

Structure Therapeutics (NASDAQ:GPCR) Coverage Initiated by Analysts at William Blair - MarketBeat

Mar 01, 2025

Feb 28, 2025

Structure Therapeutics Advances in Obesity Treatment Pipeline - TipRanks

Feb 28, 2025

Feb 28, 2025

Structure Therapeutics (NASDAQ:GPCR) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Structure Therapeutics (NASDAQ:GPCR) Shares Up 8% on Earnings Beat - MarketBeat

Feb 28, 2025

Feb 28, 2025

Structure Therapeutics, Inc.: Promising Outlook with Aleniglipron in Obesity Treatment and Strategic Advancements Justify Buy Rating - TipRanks

Feb 28, 2025

Feb 28, 2025

Promising Potential of Structure Therapeutics’ Aleniglipron: A Compelling Buy Recommendation - TipRanks

Feb 28, 2025

Feb 28, 2025

JMP cuts Structure Therapeutics price target to $87 - Investing.com

Feb 28, 2025

Feb 28, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $81.29 Average Price Target from Brokerages - MarketBeat

Feb 28, 2025

Feb 28, 2025

Buy Rating for Structure Therapeutics: Promising Phase 2b Trials and Strong Financial Position - TipRanks

Feb 28, 2025

Feb 28, 2025

Structure Therapeutics (NASDAQ:GPCR) Hits New 52-Week LowTime to Sell? - MarketBeat

Feb 28, 2025

Feb 27, 2025

Structure Therapeutics reports Q4 net loss $36.5M vs. net loss $24.5M last year - TipRanks

Feb 27, 2025

Feb 27, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading Down 6.4%Time to Sell? - MarketBeat

Feb 27, 2025

Feb 27, 2025

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights - The Manila Times

Feb 27, 2025

Feb 27, 2025

Can Structure Therapeutics' Obesity Drug Challenge Wegovy? Trial Enrollment Complete - StockTitan

Feb 27, 2025

Feb 26, 2025

GPCR stock touches 52-week low at $20.11 amid market challenges By Investing.com - Investing.com South Africa

Feb 26, 2025

Feb 26, 2025

GPCR stock touches 52-week low at $20.11 amid market challenges - Investing.com India

Feb 26, 2025

Feb 25, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading Up 6.2%Here's Why - MarketBeat

Feb 25, 2025

Feb 24, 2025

Handelsbanken Fonder AB Purchases Shares of 165,000 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Feb 24, 2025

Feb 20, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Sees Large Decline in Short Interest - MarketBeat

Feb 20, 2025

Feb 19, 2025

GPCR Stock Hits 52-Week Low at $23.48 Amid Market Challenges - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

Nebius Group: NVIDIA’s Investment Sparks All-Time Highs - The Globe and Mail

Feb 19, 2025

Feb 19, 2025

Structure Therapeutics (NASDAQ:GPCR) Sets New 52-Week Low – Here’s What Happened - Defense World

Feb 19, 2025

Feb 18, 2025

Best Growth Stock: Tesla Stock vs. Arm Stock - The Globe and Mail

Feb 18, 2025

Feb 14, 2025

Why Structure Therapeutics Stock Was Stumbling This Week - The Globe and Mail

Feb 14, 2025

Feb 14, 2025

abrdn plc Sells 45,695 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Feb 14, 2025

Feb 11, 2025

Financial Fitness Check: Examining Structure Therapeutics Inc ADR (GPCR)’s Key Ratios - The Dwinnex

Feb 11, 2025

Feb 11, 2025

Spire Wealth Management Acquires Shares of 8,949 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Feb 11, 2025

Feb 11, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading Down 6.7%Should You Sell? - MarketBeat

Feb 11, 2025

Feb 10, 2025

HSBC Securities Downgrades Morgan Stanley (MS) to a Hold from a Buy - Knox Daily

Feb 10, 2025

Feb 10, 2025

JD.com Inc ADR (JD) receives an Outperform rating from Bernstein - Knox Daily

Feb 10, 2025